Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |